Get our free email newsletter

U.S. FDA Publishes Updated Checklist for PMA Reviews

The U.S. Food and Drug Administration (FDA) has issued an updated version of its guidance on premarket approval (PMA) application submissions and reviews for medical devices.

Published in late February, the updated version of its guidance “Acceptance and Filing Review for Premarket Approval Applications (PMAs)” is “not significantly different” from the prior version, originally issued in 2003. Instead, the revision separates the criteria for a PMA filing into acceptance criteria and filing criteria, and further clarifies the necessary elements and contents of the completed PMA application. In this way, the Agency hopes that the revised guidance will help applicants more fully address the pre-clinical and clinical issues required in a PMA, thereby minimizing unnecessary delays in the review and approval process.

As always, this and other guidance documents issued by the FDA are only intended to provide regulators and the industry with insight into the Agency’s current thinking on a given topic, and do not constitute regulations or any other legally enforceable responsibilities.

- Partner Content -

A Dash of Maxwell’s: A Maxwell’s Equations Primer – Part Two

Maxwell’s Equations are eloquently simple yet excruciatingly complex. Their first statement by James Clerk Maxwell in 1864 heralded the beginning of the age of radio and, one could argue, the age of modern electronics.

Read the final FDA guidance on PMA reviews.

Related Articles

Digital Sponsors

Become a Sponsor

Discover new products, review technical whitepapers, read the latest compliance news, and check out trending engineering news.

Get our email updates

What's New

- From Our Sponsors -

Sign up for the In Compliance Email Newsletter

Discover new products, review technical whitepapers, read the latest compliance news, and trending engineering news.